CHINA PHARMACEUTICALS INC Net Income
CHINA PHARMACEUTICALS INC reported Net Income of -$1.36 million for the 3-month period ending 2012-06-30, per its 10-Q/A filed 2012-08-27.
Discontinued › Income Statement
us-gaap:NetIncomeLoss · last filed 2012-08-27
- CHINA PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2012-06-30 was -$1.36M.
- CHINA PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2012-03-31 was -$401.31K, a 113.90% decline year-over-year.
- CHINA PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2011-12-31 was -$5.88M, a 507.94% decline year-over-year.
- CHINA PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2011-09-30 was $676.11K, a 28.98% decline year-over-year.
- CHINA PHARMACEUTICALS INC net income (loss) attributable to parent for fiscal 2011 was -$3.84M, a 145.64% decline from fiscal 2010.
- CHINA PHARMACEUTICALS INC net income (loss) attributable to parent for fiscal 2010 was $8.41M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2012-06-30 | -$1.36M 10-Q/A · filed 2012-08-27 | -$1.76M 10-Q/A · filed 2012-08-27 | -$7.65M derived: sum of 3 quarters · filed 2012-08-27 | -$6.97M derived: sum of 4 quarters · filed 2012-08-27 |
| 2012-03-31 | -$401.31K 10-Q · filed 2012-05-21 | -$6.28M derived: sum of 2 quarters · filed 2012-05-21 | -$5.61M derived: sum of 3 quarters · filed 2012-05-21 | -$7.13M derived: sum of 4 quarters · filed 2012-08-27 |
| 2011-12-31 | -$5.88M derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-07 | -$5.20M derived: sum of 2 quarters · filed 2012-05-07 | -$6.73M derived: sum of 3 quarters · filed 2012-08-27 | -$3.84M 10-K · filed 2012-05-07 |
| 2011-09-30 | $676.11K 10-Q · filed 2011-11-21 | -$845.46K derived: sum of 2 quarters · filed 2012-08-27 | $2.04M 10-Q · filed 2011-11-21 | $3.48M derived: sum of 4 quarters · filed 2012-08-27 |
| 2011-06-30 | -$1.52M 10-Q/A · filed 2012-08-27 | $1.37M 10-Q/A · filed 2012-08-27 | $2.81M derived: sum of 3 quarters · filed 2012-08-27 | $3.76M derived: sum of 4 quarters · filed 2012-08-27 |
| 2011-03-31 | $2.89M 10-Q · filed 2012-05-21 | $4.33M derived: sum of 2 quarters · filed 2012-05-21 | $5.28M derived: sum of 3 quarters · filed 2012-05-21 | $10.65M derived: sum of 4 quarters · filed 2012-05-21 |
| 2010-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-07 | $2.39M derived: sum of 2 quarters · filed 2012-05-07 | $7.76M derived: sum of 3 quarters · filed 2012-05-07 | $8.41M 10-K · filed 2012-05-07 |
| 2010-09-30 | $952.00K 10-Q · filed 2011-11-21 | $6.32M derived: sum of 2 quarters · filed 2011-11-21 | $6.97M 10-Q · filed 2011-11-21 | |
| 2010-06-30 | $5.37M 10-Q/A · filed 2011-09-16 | $6.02M 10-Q/A · filed 2012-06-20 |